(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 10.08%546.2M | 9.26%391.6M | 42.99%388.8M | 15.80%1.46B | 3.13%335.7M | 6.07%496.2M | 48.28%358.4M | 19.41%271.9M | 6.77%1.26B | 0.74%325.5M |
Net income from continuing operations | -9.18%189.9M | 20.61%206.6M | 47.67%167.6M | 6.44%635.1M | -0.91%141.2M | 15.65%209.1M | 9.60%171.3M | -3.07%113.5M | 1.41%596.7M | -13.37%142.5M |
Operating gains losses | ---- | -200.00%-5.7M | -184.48%-9.8M | -86.77%2.5M | -64.02%5.9M | -81.94%-13.1M | -176.00%-1.9M | --11.6M | 197.42%18.9M | 4,200.00%16.4M |
Depreciation and amortization | -2.47%232.9M | -5.19%237.6M | 25.31%236.2M | 18.41%909M | 21.70%231.1M | 24.70%238.8M | 30.79%250.6M | -3.18%188.5M | -2.05%767.7M | -3.90%189.9M |
Asset impairment expenditure | -82.50%1.4M | --8M | --2.4M | 129.73%8.5M | -44.44%500K | 185.71%8M | --0 | --0 | 146.67%3.7M | 28.57%900K |
Unrealized gains and losses of investment securities | --0 | --0 | --0 | -150.00%-400K | ---100K | -160.00%-300K | 50.00%300K | -104.11%-300K | 105.56%800K | --0 |
Deferred tax | -28.47%10.3M | 2,100.00%6.6M | -28.84%-27.7M | 110.58%6.7M | 227.36%13.5M | 263.64%14.4M | 102.13%300K | 27.85%-21.5M | -5.68%-63.3M | -17.78%-10.6M |
Other non cashItems | -76.09%1.1M | -290.63%-6.1M | 275.00%3M | 661.54%9.9M | 138.24%1.3M | 15.00%4.6M | 366.67%3.2M | -57.89%800K | -98.55%1.3M | -217.24%-3.4M |
Change In working capital | 218.73%110.6M | 15.29%-55.4M | 182.61%17.1M | -72.90%-109.1M | -465.69%-57.7M | -66.70%34.7M | 30.13%-65.4M | 67.40%-20.7M | 66.27%-63.1M | 60.77%-10.2M |
-Change in receivables | ---- | ---- | ---- | -1,716.67%-141.7M | ---- | ---- | ---- | ---- | 93.32%-7.8M | ---- |
-Change in inventory | ---- | ---- | ---- | 81.39%-25.8M | ---- | ---- | ---- | ---- | -195.52%-138.6M | ---- |
-Change in payables and accrued expense | ---- | ---- | ---- | 7.16%86.8M | ---- | ---- | ---- | ---- | 244.68%81M | ---- |
-Change in other working capital | ---- | ---- | ---- | -1,334.78%-28.4M | ---- | ---- | ---- | ---- | 104.89%2.3M | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 10.08%546.2M | 9.26%391.6M | 42.99%388.8M | 15.80%1.46B | 3.13%335.7M | 6.07%496.2M | 48.28%358.4M | 19.41%271.9M | 6.77%1.26B | 0.74%325.5M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -26.53%-189.8M | 81.19%-417.7M | -31.02%-203.6M | -324.12%-2.68B | -25.70%-151.6M | 14.33%-150M | -1,160.93%-2.22B | 2.57%-155.4M | 54.06%-631.3M | 86.65%-120.6M |
Capital expenditure reported | -23.00%-172.2M | -25.96%-171.3M | ---- | ---- | ---- | ---140M | ---136M | ---- | ---- | ---- |
Net PPE purchase and sale | ---- | ---- | 17.81%-90M | 15.80%-436.3M | ---- | ---- | ---- | 13.78%-109.5M | -94.16%-518.2M | 24.49%-99.3M |
Net intangibles purchas and sale | --0 | ---239.1M | -117.11%-99M | -81.95%-166.3M | -610.91%-156.4M | --0 | --0 | -53.02%-45.6M | 91.03%-91.4M | 96.88%-22M |
Net business purchase and sale | --0 | 99.66%-7M | ---- | -9,264.71%-2.07B | --0 | 90.16%-1.8M | -54,315.79%-2.07B | ---- | -5.24%-22.1M | --0 |
Net investment purchase and sale | -528.57%-17.6M | 75.76%-800K | -2,333.33%-14.6M | -6.06%-7M | -250.00%-300K | -600.00%-2.8M | -43.48%-3.3M | 85.37%-600K | 91.22%-6.6M | 100.30%200K |
Net other investing changes | ---- | 103.73%500K | ---- | -75.71%1.7M | 7,940.00%40.2M | -640.00%-5.4M | -426.83%-13.4M | -78.57%300K | -9.09%7M | -66.67%500K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -26.53%-189.8M | 81.19%-417.7M | -31.02%-203.6M | -324.12%-2.68B | -25.70%-151.6M | 14.33%-150M | -1,160.93%-2.22B | 2.57%-155.4M | 54.06%-631.3M | 86.65%-120.6M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 12.23%-310.1M | -99.56%8.3M | 2.77%-133.4M | 245.27%1.18B | 22.22%-198.1M | -21.53%-353.3M | 1,543.32%1.87B | 0.36%-137.2M | -388.26%-812.6M | -304.91%-254.7M |
Net issuance payments of debt | 30.40%-192.8M | -98.85%23M | 69.98%-133.4M | 498.62%1.16B | 15.33%-128.1M | -99.42%-277M | 1,705.58%2.01B | -298.12%-444.3M | -144.82%-290.6M | -161.16%-151.3M |
Net common stock issuance | -478.87%-41.1M | ---27.7M | ---- | 96.71%-7.8M | 97.89%-700K | 91.20%-7.1M | --0 | ---- | 16.08%-237M | 41.24%-33.2M |
Cash dividends paid | -10.12%-76.2M | -8.15%-149.9M | ---- | 1.77%-277.1M | 0.43%-69.1M | 1.14%-69.2M | 2.87%-138.6M | ---- | -5.42%-282.1M | -5.47%-69.4M |
Net other financing activities | ---- | 163,000.00%162.9M | ---- | 10,686.21%307M | 75.00%-200K | ---- | 88.89%-100K | 307,200.00%307.1M | -101.58%-2.9M | 0.00%-800K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 12.23%-310.1M | -99.56%8.3M | 2.77%-133.4M | 245.27%1.18B | 22.22%-198.1M | -21.53%-353.3M | 1,543.32%1.87B | 0.36%-137.2M | -388.26%-812.6M | -304.91%-254.7M |
Net cash flow | ||||||||||
Beginning cash position | 40.06%45.1M | 149.60%62.9M | -75.82%11.1M | -79.79%45.9M | -73.77%25.1M | -65.64%32.2M | -84.01%25.2M | -79.79%45.9M | 66.13%227.1M | -85.99%95.7M |
Current changes in cash | 752.11%46.3M | -354.29%-17.8M | 350.24%51.8M | 80.79%-34.8M | 71.89%-14M | -455.00%-7.1M | 110.95%7M | 70.22%-20.7M | -300.44%-181.2M | 89.08%-49.8M |
End cash Position | 264.14%91.4M | 40.06%45.1M | 149.60%62.9M | -75.82%11.1M | -75.82%11.1M | -73.77%25.1M | -65.64%32.2M | -84.01%25.2M | -79.79%45.9M | -79.79%45.9M |
Free cash from | 5.00%374M | -108.45%-18.8M | 39.38%162.8M | 31.62%859.6M | -29.38%144.2M | 14.76%356.2M | 228.99%222.4M | 64.74%116.8M | 346.08%653.1M | 143.03%204.2M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data